• ctDNA Sampling May Help Tailor Treatment for Difficult-to-Treat Ovarian Cancer, Study Suggests
  • Dutch Researchers Develop Mini Ovarian Cancers to Improve Personalized Therapies
  • Lynparza Recommended for Approval in Europe for BRCA-mutated Advanced OC
  • Few Ovarian Cancer Patients Get Recommended Genetic Tests that Could Guide Care, Study Shows
  • New Imaging-Guided System Helps Surgeons Remove Tiny Ovarian Tumors
  • Ovarian Cancer Patients Being Recruited to Test HPN536 Immunotherapy in Phase 1/2a Trial
  • Study Ranks Gene Targets for More Effective, Tailored Cancer Therapies
  • Surgeons Will Test LUM Imaging System to Better Detect Ovarian, Other Cancer Cells
  • Lynparza Plus Investigational Alpelisib Is Promising for Epithelial Ovarian Cancer
  • BRCA1/2 Protection Factor Decreases over Time in Epithelial Ovarian Cancer, Study Reports
  • Myriad Seeks FDA Approval of myChoice HRD CDx Diagnostic Test for Ovarian Cancer Patients
  • Long-term Use of Oral Contraceptives Protects Against Deadliest Forms of Ovarian Cancer, Large Study Finds